Tenders of Aok Plus Die Gesundheitskasse F R Sachsen Und Th Ringen
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Civil And Construction...+1Civil Works Others
Germany
Conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient trazodone (ATC code according to WHO: N06AX05)
Closing Date31 May 2027
Tender AmountRefer Documents
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient posaconazole (ATC code according to WHO: J02AC04)
Closing Date31 May 2027
Tender AmountRefer Documents
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Beclometason/formoterol (atc-code Nach Who: R03ak08)
Closing Date31 May 2026
Tender AmountRefer Documents
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Civil And Construction...+1Civil Works Others
Germany
Conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 of the Social Security Code V by means of an open-house model for the active ingredient beclometason/formoterol (ATC code according to WHO: R03AK08)
Closing Date31 May 2026
Tender AmountRefer Documents
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Others
Germany
Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Security Code (SGB V) by means of an open-house model for the active ingredient Epoetin Zeta (recombinant human erythropoietin)
Closing Date30 Apr 2027
Tender AmountRefer Documents
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Others
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Interferon Beta-1a Zur Subkutanen Injektion (atc-code Nach Who: L03ab07)
Closing Date30 Apr 2026
Tender AmountRefer Documents
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Raltegravir 400 Mg (atc-code Nach Who: J05aj01)
Closing Date30 Jun 2026
Tender AmountRefer Documents
AOK PLUS Die Gesundheitskasse F R Sachsen Und Th Ringen Tender
Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Raltegravir 600 Mg (atc-code Nach Who: J05aj01)
Closing Date30 Jun 2026
Tender AmountRefer Documents
41-50 of 199 active Tenders